5Y6-15000-12330
5 vaccinations
6 coded responses
56 check-ins
6 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 66+
- ZIP prefix
- 024 / MA
- Registered
- 2021-02-04
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-02-04
Registered in v-safe
-
2021-02-04
Dose 1 — Pfizer-BioNTech
- 2021-02-04
-
2021-02-06
Survey response — days 1–6 daily, dose 1MedDRA: Injection site discomfort — Feeling: Good · Site: Pain, SwellingFree text: Pain not really descriptive; more like a little soreness at the injection site. It disappeared on the second day after the injection.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-02-07
- 2021-02-08
- 2021-02-09
- 2021-02-11
- 2021-02-18
-
2021-02-25
Dose 2 — Pfizer-BioNTech
- 2021-02-25
-
2021-02-26
Survey response — days 1–6 daily, dose 2MedDRA: Injection site pain, Injection site swelling — Feeling: GoodFree text: Some soreness and swelling at the injection site last night. Both subsided by this morning.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-02-27
- 2021-02-28
- 2021-03-01
- 2021-03-02
- 2021-03-03
- 2021-03-04
- 2021-03-11
- 2021-03-18
- 2021-03-25
- 2021-04-01
- 2021-04-08
- 2021-05-27
-
2021-08-26
Survey response — 6 months, dose 2MedDRA: Exposure to SARS-CoV-2, Malaise, Quarantine, SARS-CoV-2 test positive — Feeling: Good · Be unable to do your normal daily activitiesFree text: Exposed to confirmed case of COVID-19 and had symptoms 4 1/2 days later. Tested positive. Quarantined for 10 days but added days because my partner caught it from me. Retested negative after those days passed.MedDRA releases: 2021-09,2024-11 · check-in free text available
-
2021-12-07
Dose 3 — Moderna
- 2021-12-08
- 2021-12-09
- 2021-12-10
- 2021-12-11
- 2021-12-12
- 2021-12-13
- 2021-12-14
- 2021-12-21
- 2021-12-28
- 2022-01-04
-
2022-01-12
Survey response — day 35, dose 3MedDRA: Headache — Feeling: GoodFree text: Minor headache.MedDRA releases: 2024-11 · check-in free text available
- 2022-01-18
- 2022-03-08
-
2022-04-06
Dose 4 — Moderna
-
2022-04-20
Survey response — day 14, dose 4MedDRA: Arthritis — Feeling: GoodFree text: Arthritis at base of left thumbMedDRA releases: 2024-11 · check-in free text available
- 2022-04-27
- 2022-05-06
- 2022-05-11
- 2022-05-18
- 2022-07-06
-
2022-09-26
Dose 5 — Moderna
- 2022-09-26
- 2022-09-27
- 2022-09-28
- 2022-09-29
- 2022-09-30
- 2022-10-01
- 2022-10-02
- 2022-10-03
- 2022-10-10
-
2022-10-17
Survey response — day 21, dose 5MedDRA: Abdominal pain upper, Body temperature increased, Tissue rupture — Feeling: Good · Be unable to do your normal daily activitiesFree text: After a strenuous personal training lesson, I must have torn internal lower stomach tissues and experienced pain and slightly elevated body temperature. Lasted about 3 days.MedDRA releases: 2024-11 · check-in free text available
- 2022-10-24
- 2022-10-31
- 2022-11-07
- 2022-12-26
- 2023-03-27
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-02-04 | Pfizer-BioNTech | |
| 2 | 2021-02-25 | Pfizer-BioNTech | |
| 3 | 2021-12-07 | Moderna | No |
| 4 | 2022-04-06 | Moderna | No |
| 5 | 2022-09-26 | Moderna | No |
Free text
Release 3 — days 1–6 daily, dose 1
Systemic reaction (other): Pain not really descriptive; more like a little soreness at the injection site. It disappeared on the second day after the injection.
Release 4 — days 1–6 daily, dose 2
Systemic reaction (other): Some soreness and swelling at the injection site last night. Both subsided by this morning.
Release 9 — 6 months, dose 2
Symptoms: Exposed to confirmed case of COVID-19 and had symptoms 4 1/2 days later. Tested positive. Quarantined for 10 days but added days because my partner caught it from me. Retested negative after those days passed.
Release 10 — day 35, dose 3
Symptoms: Minor headache.
Release 11 — day 14, dose 4
Symptoms: Arthritis at base of left thumb
Release 12 — day 21, dose 5
Symptoms: After a strenuous personal training lesson, I must have torn internal lower stomach tissues and experienced pain and slightly elevated body temperature. Lasted about 3 days.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Abdominal pain upper | · | · | ✓ |
| SD | Arthritis | · | · | ✓ |
| SD | Body temperature increased | · | · | ✓ |
| SD | Exposure to SARS-CoV-2 | ✓ | · | ✓ |
| SD | Headache | · | · | ✓ |
| SD | Malaise | ✓ | · | ✓ |
| SD | Quarantine | ✓ | · | ✓ |
| SD | SARS-CoV-2 test positive | ✓ | · | ✓ |
| SD | Tissue rupture | · | · | ✓ |
| SRO | Injection site discomfort | ✓ | ✓ | ✓ |
| SRO | Injection site pain | ✓ | ✓ | ✓ |
| SRO | Injection site swelling | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release